You are here

  • Home
  • Archive
  • Volume 15, Issue 6
  • Intensive dietary advice significantly improves HbA(1c) in patients with type II diabetes who remain hyperglycaemic despite optimised drug treatment

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Intensive dietary advice significantly improves HbA(1c) in patients with type II diabetes who remain hyperglycaemic despite optimised drug treatment
  1. Deborah J Wexler,
  2. Richard W Grant
  1. Massachusetts General Hospital, Boston, Massachusetts, USA
  1. Correspondence to Richard W Grant
    Massachusetts General Hospital, 50 Staniford St, 9th Floor, Boston, MA 02114, USA; rgrant{at}partners.org

https://doi.org/10.1136/ebm1139

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on:

    1. Coppell KJ,
    2. Kataoka M,
    3. Williams SM,
    4. et al
    . Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment–Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ 2010;341:c3337.
    OpenUrlAbstract/FREE Full Text

    Context

    An oft-repeated but little heeded tenet of diabetes care is that diet and exercise are the foundation of therapy. This study aimed to test the value of an intensive nutritional intervention in patients with type II diabetes that remained uncontrolled despite aggressive drug treatment.

    Methods

    This was an unblinded, randomised clinical trial of intensive dietary advice compared with usual care for type II diabetes patients on ‘optimised’ drug therapy conducted between 2006 and 2009 in New Zealand. Eligible patients were adults younger than 70 years of age who had at least two of three cardiovascular risk factors (overweight/obese, hypertensive or on anti-hypertensive medications, and dyslipidaemic or on lipid-lowering therapy) and an HbA1c >7% despite drug therapy. Subjects with serious chronic illness or pregnancy were excluded, as were subjects who would be unwilling to adopt dietary and lifestyle changes. …

    View Full Text

    Footnotes

    • Competing interests None.